机译:发现螺氧唑氮二酮作为P300 / CBP组氨酸乙酰转移酶的选择性,口服生物可爱抑制剂
AbbVie Inc 1 North Waukegan Rd N Chicago IL 60064 USA;
Acylin Therapeut Inc 1616 Eastlake Ave E Suite 200 Seattle WA 98012 USA;
Acylin Therapeut Inc 1616 Eastlake Ave E Suite 200 Seattle WA 98012 USA;
Acylin Therapeut Inc 1616 Eastlake Ave E Suite 200 Seattle WA 98012 USA;
BioDuro 29 Life Sci Pk Rd Beijing 102206 Peoples R China;
AbbVie Inc 1 North Waukegan Rd N Chicago IL 60064 USA;
AbbVie Inc 1 North Waukegan Rd N Chicago IL 60064 USA;
AbbVie Inc 1 North Waukegan Rd N Chicago IL 60064 USA;
Acylin Therapeut Inc 1616 Eastlake Ave E Suite 200 Seattle WA 98012 USA;
Acylin Therapeut Inc 1616 Eastlake Ave E Suite 200 Seattle WA 98012 USA;
Acylin Therapeut Inc 1616 Eastlake Ave E Suite 200 Seattle WA 98012 USA;
Acylin Therapeut Inc 1616 Eastlake Ave E Suite 200 Seattle WA 98012 USA;
Acylin Therapeut Inc 1616 Eastlake Ave E Suite 200 Seattle WA 98012 USA;
Acylin Therapeut Inc 1616 Eastlake Ave E Suite 200 Seattle WA 98012 USA;
Acylin Therapeut Inc 1616 Eastlake Ave E Suite 200 Seattle WA 98012 USA;
Acylin Therapeut Inc 1616 Eastlake Ave E Suite 200 Seattle WA 98012 USA;
AbbVie Inc 1 North Waukegan Rd N Chicago IL 60064 USA;
AbbVie Inc 1 North Waukegan Rd N Chicago IL 60064 USA;
AbbVie Inc 1 North Waukegan Rd N Chicago IL 60064 USA;
AbbVie Inc 1 North Waukegan Rd N Chicago IL 60064 USA;
Acylin Therapeut Inc 1616 Eastlake Ave E Suite 200 Seattle WA 98012 USA;
p300; CBP; histone acetyl transferase;
机译:发现螺氧唑氮二酮作为P300 / CBP组氨酸乙酰转移酶的选择性,口服生物可爱抑制剂
机译:CPI-1612的发现:有效,选择性和口服生物可利用的EP300 / CBP组氨酸乙酰转移酶抑制剂
机译:发现高效,选择性和口服有效的P300 / CBP组氨基乙酰转移酶抑制剂
机译:CNX-774,Bruton的酪氨酸激酶的不可逆转,选择性和口服生物可利用的抑制剂:体外Adme,选择性和药代动力学性能
机译:组蛋白乙酰转移酶p300 / CBP是黑色素瘤中功能上重要的靶标。
机译:发现螺恶唑烷二酮类化合物具有选择性p300 / CBP组蛋白乙酰基转移酶的口服生物利用抑制剂
机译:CPI-1612的发现:一种有效的,选择性和口服生物可利用的EP300 / CBP组氨酸乙酰转移酶抑制剂